Published in J Virol on January 13, 2010
Specific inhibition of diverse pathogens in human cells by synthetic microRNA-like oligonucleotides inferred from RNAi screens. Proc Natl Acad Sci U S A (2014) 2.25
Comprehensive analysis of endogenous bornavirus-like elements in eukaryote genomes. Philos Trans R Soc Lond B Biol Sci (2013) 0.98
Cell-based genomic screening: elucidating virus-host interactions. Curr Opin Virol (2012) 0.97
Analysis of virion-incorporated host proteins required for herpes simplex virus type 1 infection through a RNA interference screen. PLoS One (2013) 0.92
Non-retroviral fossils in vertebrate genomes. Viruses (2011) 0.87
A loss of function analysis of host factors influencing Vaccinia virus replication by RNA interference. PLoS One (2014) 0.82
Analysis of borna disease virus trafficking in live infected cells by using a virus encoding a tetracysteine-tagged p protein. J Virol (2013) 0.81
A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats. Exp Neurol (2010) 0.80
Enhancers of adeno-associated virus AAV2 transduction via high throughput siRNA screening. Mol Ther (2011) 0.80
Co-expression analysis of differentially expressed genes in hepatitis C virus-induced hepatocellular carcinoma. Mol Med Rep (2014) 0.76
Molecular Mechanisms of Innate Immune Inhibition by Non-Segmented Negative-Sense RNA Viruses. J Mol Biol (2016) 0.76
Regulated portals of entry into the cell. Nature (2003) 15.33
Identification of host proteins required for HIV infection through a functional genomic screen. Science (2008) 12.44
Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science (2005) 7.07
Virus entry: open sesame. Cell (2006) 6.33
Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. Nature (2005) 5.30
RNA interference screen for human genes associated with West Nile virus infection. Nature (2008) 4.93
Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening. Mol Cell (2003) 4.25
ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha. Mol Biol Cell (2009) 2.46
Borna disease virus, a negative-strand RNA virus, transcribes in the nucleus of infected cells. Proc Natl Acad Sci U S A (1992) 2.44
The remarkable coding strategy of borna disease virus: a new member of the nonsegmented negative strand RNA viruses. Virology (1995) 2.17
Natural and experimental Borna disease in animals. Curr Top Microbiol Immunol (1995) 2.11
Novel borna virus in psittacine birds with proventricular dilatation disease. Emerg Infect Dis (2008) 2.10
Borna disease virus (BDV), a nonsegmented RNA virus, replicates in the nuclei of infected cells where infectious BDV ribonucleoproteins are present. J Virol (1994) 1.93
Epidemiology of Borna disease virus. J Gen Virol (2000) 1.89
Molecular biology of borna disease virus: prototype of a new group of animal viruses. J Virol (1994) 1.83
Comparison of MTT and ATP-based assays for the measurement of viable cell number. J Biolumin Chemilumin (1995) 1.67
Sequence conservation in field and experimental isolates of Borna disease virus. J Virol (1994) 1.67
Broad tissue and cell tropism of avian bornavirus in parrots with proventricular dilatation disease. J Virol (2009) 1.57
Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption. J Med Virol (2002) 1.55
An infection-based model of neurodevelopmental damage. Proc Natl Acad Sci U S A (1999) 1.53
Small interfering RNA profiling reveals key role of clathrin-mediated endocytosis and early endosome formation for infection by respiratory syncytial virus. J Virol (2007) 1.49
Analysis of filovirus entry into vero e6 cells, using inhibitors of endocytosis, endosomal acidification, structural integrity, and cathepsin (B and L) activity. J Infect Dis (2007) 1.46
The dynein light chain 8 binding motif of rabies virus phosphoprotein promotes efficient viral transcription. Proc Natl Acad Sci U S A (2007) 1.42
African swine fever virus protein p54 interacts with the microtubular motor complex through direct binding to light-chain dynein. J Virol (2001) 1.34
Clinical and serological response to laboratory-acquired human infection by Indiana type vesicular stomatitis virus (VSV). Am J Trop Med Hyg (1966) 1.34
Characterization of Borna disease virus p56 protein, a surface glycoprotein involved in virus entry. J Virol (1997) 1.33
N-terminal domain of Borna disease virus G (p56) protein is sufficient for virus receptor recognition and cell entry. J Virol (2001) 1.32
Selective disruption of growth hormone transcription machinery by viral infection. Proc Natl Acad Sci U S A (1992) 1.29
The shedding activity of ADAM17 is sequestered in lipid rafts. Exp Cell Res (2006) 1.26
Borna disease virus and the brain. Brain Res Bull (1997) 1.23
Borna disease virus and infection in humans. Front Biosci (2002) 1.21
Mechanism of Borna disease virus entry into cells. J Virol (1998) 1.20
Increase of virus yields and releases of Borna disease virus from persistently infected cells. Virus Res (1985) 1.20
Novel insights into the regulation of the viral polymerase complex of neurotropic Borna disease virus. Virus Res (2005) 1.19
Borna disease virus infection of the neonatal rat: developmental brain injury model of autism spectrum disorders. Front Biosci (2002) 1.13
Molecular motors hijacking by intracellular pathogens. Cell Microbiol (2006) 1.08
Targeting host cell furin proprotein convertases as a therapeutic strategy against bacterial toxins and viral pathogens. J Biol Chem (2007) 1.08
Processing of the Borna disease virus glycoprotein gp94 by the subtilisin-like endoprotease furin. J Virol (1998) 1.08
Borna disease virus infection in animals and humans. Emerg Infect Dis (1997) 1.07
Borna disease virus glycoprotein is required for viral dissemination in neurons. J Virol (2003) 1.02
NAADP-induced Ca(2+ signaling in response to endothelin is via the receptor subtype B and requires the integrity of lipid rafts/caveolae. J Cell Physiol (2008) 1.00
Cathepsin L2, a novel human cysteine proteinase produced by breast and colorectal carcinomas. Cancer Res (1998) 0.99
Borna disease. Emerg Infect Dis (1997) 0.98
Two pools of Triton X-100-insoluble GABA(A) receptors are present in the brain, one associated to lipid rafts and another one to the post-synaptic GABAergic complex. J Neurochem (2007) 0.97
Infectious and immune factors in the pathogenesis of neurodevelopmental disorders: epidemiology, hypotheses, and animal models. Ment Retard Dev Disabil Res Rev (2001) 0.96
Abnormal social behaviors in young and adult rats neonatally infected with Borna disease virus. Behav Brain Res (2006) 0.96
Soluble LDL minireceptors. Minimal structure requirements for recognition of minor group human rhinovirus. J Biol Chem (1998) 0.92
Cell-to-cell spread of Borna disease virus proceeds in the absence of the virus primary receptor and furin-mediated processing of the virus surface glycoprotein. J Virol (2007) 0.91
Borna disease virus requires cholesterol in both cellular membrane and viral envelope for efficient cell entry. J Virol (2009) 0.87
Role of clathrin-coated vesicles in glycoprotein transport from the cell surface to the Golgi complex. J Biol Chem (1995) 0.86
The structure and regulation of the human and mouse matrix metalloproteinase-21 gene and protein. Biochem J (2003) 0.85
Generation and characterization of a recombinant vesicular stomatitis virus expressing the glycoprotein of Borna disease virus. J Virol (2007) 0.84
Neurobiology of Borna disease virus. J Neurovirol (1997) 0.84
Crystallization and preliminary X-ray analysis of human rhinovirus serotype 2 (HRV2). Acta Crystallogr D Biol Crystallogr (1999) 0.77
Functional genomic screen for modulators of ciliogenesis and cilium length. Nature (2010) 3.63
The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci U S A (2003) 3.34
Translational homeostasis via the mRNA cap-binding protein, eIF4E. Mol Cell (2012) 2.19
RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis. Proc Natl Acad Sci U S A (2010) 1.94
Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest. Proc Natl Acad Sci U S A (2009) 1.72
Chemokine guidance of central memory T cells is critical for antiviral recall responses in lymph nodes. Cell (2012) 1.70
Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol (2009) 1.61
Rescue of the prototypic Arenavirus LCMV entirely from plasmid. Virology (2006) 1.58
Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence. Proc Natl Acad Sci U S A (2011) 1.47
Arenavirus Z-glycoprotein association requires Z myristoylation but not functional RING or late domains. J Virol (2007) 1.27
Differential regulation of the TRAIL death receptors DR4 and DR5 by the signal recognition particle. Mol Biol Cell (2004) 1.22
Structural characterization of the Z RING-eIF4E complex reveals a distinct mode of control for eIF4E. Proc Natl Acad Sci U S A (2010) 1.14
Arenavirus nucleoproteins prevent activation of nuclear factor kappa B. J Virol (2012) 1.14
Arenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategies. Virology (2011) 1.10
Functional specialization in proline biosynthesis of melanoma. PLoS One (2012) 1.06
Identification of MicroRNAs that control lipid droplet formation and growth in hepatocytes via high-content screening. J Biomol Screen (2010) 1.05
Genetic and biochemical evidence for an oligomeric structure of the functional L polymerase of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol (2005) 1.05
Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses. J Virol (2010) 1.03
Arenavirus genetic diversity and its biological implications. Infect Genet Evol (2009) 1.03
Loss of anti-viral immunity by infection with a virus encoding a cross-reactive pathogenic epitope. PLoS Pathog (2012) 0.99
RNAi and HTS: exploring cancer by systematic loss-of-function. Oncogene (2004) 0.95
Cell entry of Borna disease virus follows a clathrin-mediated endocytosis pathway that requires Rab5 and microtubules. J Virol (2009) 0.93
Cell-to-cell spread of Borna disease virus proceeds in the absence of the virus primary receptor and furin-mediated processing of the virus surface glycoprotein. J Virol (2007) 0.91
Degradation of newly synthesized polypeptides by ribosome-associated RACK1/c-Jun N-terminal kinase/eukaryotic elongation factor 1A2 complex. Mol Cell Biol (2013) 0.90
Self-association of lymphocytic choriomeningitis virus nucleoprotein is mediated by its N-terminal region and is not required for its anti-interferon function. J Virol (2012) 0.88
Borna disease virus requires cholesterol in both cellular membrane and viral envelope for efficient cell entry. J Virol (2009) 0.87
Effective inhibition of melanoma by BI-69A11 is mediated by dual targeting of the AKT and NF-κB pathways. Pigment Cell Melanoma Res (2011) 0.87
Novel antiviral strategies to combat human Arenavirus infections. Curr Mol Med (2005) 0.86
Mice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virus. J Virol (2013) 0.85
Inhibition of melanoma development in the Nras((Q61K)) ::Ink4a(-/-) mouse model by the small molecule BI-69A11. Pigment Cell Melanoma Res (2012) 0.84
Generation and characterization of a recombinant vesicular stomatitis virus expressing the glycoprotein of Borna disease virus. J Virol (2007) 0.84
Sodium hydrogen exchangers contribute to arenavirus cell entry. J Virol (2013) 0.82
Roquin-2 promotes ubiquitin-mediated degradation of ASK1 to regulate stress responses. Sci Signal (2014) 0.82
Exposing oncogenic dependencies for cancer drug target discovery and validation using RNAi. Semin Cancer Biol (2003) 0.81
D471G mutation in LCMV-NP affects its ability to self-associate and results in a dominant negative effect in viral RNA synthesis. Viruses (2012) 0.81
Design, synthesis, and biological evaluation of a biyouyanagin compound library. Proc Natl Acad Sci U S A (2011) 0.79
PTPome-wide functional RNA interference screening methods. Methods (2007) 0.76
Arenavirus Quasispecies and Their Biological Implications. Curr Top Microbiol Immunol (2016) 0.75